OPAL ONCOLOGY

Opal Oncology is a drug discovery company incorporated in 2012 and is based in Cambridge, UK. We have a vision for discovering and in-licensing small molecule cancer therapies... At Opal Oncology we are dedicated to breakthrough research to discover a treatment for an incurable brain cancer 'GlioblastomaMultiforme'... We work with academic groups, charitable organisations and other biotechnology companies. Opal Oncology operates on a virtualised biotech model which enables us to access the best expertise, partners and research in the marketplace.

Primary location: Cambridge United Kingdom